GIC backs Chinese drugmaker Hua Medicine’s $117.4m Series D & E round

Photographer: Krisztian Bocsi/Bloomberg

Chinese pharmaceutical company Hua Medicine has raised $117.4 million from existing and new investors in a combined Series D and Series E financing round.

Continue reading this story with a subscription to DealStreetAsia.

Subscribe

Contact us for corporate subscriptions at subs@dealstreetasia.com.